Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000950137-04-002232
Filing Date
2004-03-26
Accepted
2004-03-26 15:33:23
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT c83929e10ksb.htm 10KSB 625153
3 FIRST AMENDMENT TO LEASE, DATED 9/18/03 c83929exv10w28.txt EX-10.28 4015
4 OFFICE LEASE, DATED 12/19/03 c83929exv10w29.txt EX-10.29 165611
5 FORM OF STOCK OPTION AGREEMENT c83929exv10w30.txt EX-10.30 18018
6 FORM OF STOCK OPTION AGREEMENT c83929exv10w31.txt EX-10.31 15814
7 CODE OF CONDUCT AND ETHICS c83929exv14w1.txt EX-14.1 5349
8 CONSENT OF DELOITTE & TOUCHE LLP c83929exv23w1.txt EX-23.1 704
9 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c83929exv31w1.txt EX-31.1 3829
10 CERTIFICATION OF CHIEF FINANCIAL OFFICER c83929exv31w2.txt EX-31.2 3842
11 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c83929exv32w1.txt EX-32.1 1467
12 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER c83929exv32w2.txt EX-32.2 1472
14 GRAPHIC c83929c8392900.gif GRAPHIC 80690
  Complete submission text file 0000950137-04-002232.txt   929092
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 001-31812 | Film No.: 04692888
SIC: 2836 Biological Products, (No Diagnostic Substances)